Education

• 2015: Masters in Health Administration (MHA), School of Health Administration, Dalhousie University（Canada）
• 2008: Ph.D. (Immunology and Infectious Diseases), Faculty of Medicine, Memorial University of Newfoundland（Canada）
• 2001: M.Sc. (Animal Biotechnology), National Biotechnology Centre, Indian Veterinary Research Institute (India)
• 1998: Doctor of Veterinary Medicine (DVM), College of Veterinary Sciences and Animal Husbandry, Marathwada Agricultural University （India）

Professional Experience

• 2025 -: Full professor, Department of Pathology, Faculty of Medicine, Dalhousie University (Canada）
• 2024 -: Director of Research, Department of Pathology, Faculty of Medicine, Dalhousie University (Canada）
• 2022 -: Executive Director, Cancer Immunotherapy, Innovation & Global Partnerships, Faculty of Medicine, Dalhousie University （Canada）
• 2021- 2025: Associate professor, Department of Pathology, Faculty of Medicine, Dalhousie University (Canada)
• 2016- 2021: Assistant Professor, Department of Pathology, Faculty of Medicine, Dalhousie University (Canada)
• 2014 -2018: Program Director, The Centre for Innovative and Collaborative Health Services Research
• 2015-2018: Scientific Advisor, Immunology and Biotherapy, PhotoDynamic Inc. (CICHSR), IWK Health Centre （Canada）
• 2015-2016: Research Associate, Dalhousie University （Canada）
• 2013-2014: Scientist, Strategy and Organizational Performance, IWK Health Centre (Canada）
• 2012-2015: Post-Doctoral Fellow, Canadian Institutes of Health Research (CIHR), Dalhousie University （Canada）
• 2009-2011: Post-Doctoral Fellow, Cancer Research Training Program, Dalhousie University （Canada）

Selected Publications

GUJAR S*, Pol J*, Kumar V, Lizarralde-Guerrero M, Konda P, Kroemer G, Bell J. Tutorial: Design, Production and Testing of Oncolytic Viruses for Cancer Immunotherapy. Nature Protocols. 2024. [PMID:3876914]

GUJAR S, Bell J and Diallo JS. Cancer immunotherapy with oncolytic viruses. Cell. 2019. [PMID: 30794777].

GUJAR S*, Pol J*, Kim Y, Lee P and Kroemer G. 2018. Antitumor benefits of antiviral immunity: an underappreciated aspect of oncolytic virotherapies. Trends in Immunology. 2018 (Cell Press). S1471-4906(17)30228-4. [Selected as the cover feature of March 2018 issue of the journal, and also highlighted on Cell.com]. [PMID: 29275092].

Lee P and GUJAR S. 2018. Potentiating prostate cancer immunotherapy with oncolytic viruses. Nature Reviews Urology. 2018. [Featured on the cover page of April 2018 issue of the journal]. [PMID: 29434366].